A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic

NCT04369365 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

COVID

Interventions

DRUG: Azithromycin 500 milligram (mg) oral Tablet
DRUG: Placebo

Sponsor

Prof. Dr. Matthias Preusser